Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry.
Gabiña PM, Gleisner KS, Cremonesi M, Stokke C, Flux G, Cicone F, Konijnenberg M, Aldridge M, Sandstrom M, Chiesa C, Paphiti M, Hippeläinen E, Uribe C, Solny P, Gnesin S, Bernhardt P, Chouin N, Costa PF, Glatting G, Verburg F, Gear J. Gabiña PM, et al. Among authors: flux g. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2595-2604. doi: 10.1007/s00259-023-06215-2. Eur J Nucl Med Mol Imaging. 2023. PMID: 37129712 No abstract available.
EFOMP policy statement NO. 19: Dosimetry in nuclear medicine therapy - Molecular radiotherapy.
Sjögreen-Gleisner K, Flux G, Bacher K, Chiesa C, de Nijs R, Kagadis GC, Lima T, Georgosopoulou ML, Gabiña PM, Nekolla S, Peters S, Santos J, Sattler B, Stokke C, Tran-Gia J, Gilligan P, Bardiès M. Sjögreen-Gleisner K, et al. Among authors: flux g. Phys Med. 2023 Dec;116:103166. doi: 10.1016/j.ejmp.2023.103166. Epub 2023 Nov 4. Phys Med. 2023. PMID: 37926641 Free article. Review.
Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy.
Wadsley J, Ainsworth G, Coulson AB, Garcez K, Moss L, Newbold K, Farnell K, Swain J, Howard H, Beasley M, Weaver A, Wood K, Marshall J, Griffin M, Pascoe A, Du Y, Taprogge J, Flux G, Brown S. Wadsley J, et al. Among authors: flux g. Thyroid. 2023 Sep;33(9):1119-1123. doi: 10.1089/thy.2022.0707. Epub 2023 Sep 1. Thyroid. 2023. PMID: 37565288 Free PMC article. Clinical Trial. No abstract available.
Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project.
Taprogge J, Vergara-Gil A, Leek F, Abreu C, Vávrová L, Carnegie-Peake L, Schumann S, Eberlein U, Lassmann M, Schurrat T, Luster M, Verburg FA, Vallot D, Vija L, Courbon F, Newbold K, Bardiès M, Flux G. Taprogge J, et al. Among authors: flux g. Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3225-3234. doi: 10.1007/s00259-023-06295-0. Epub 2023 Jun 10. Eur J Nucl Med Mol Imaging. 2023. PMID: 37300572 Free PMC article.
Radiation protection aspects for alpha therapies.
Craig AJ, Taprogge J, Flux GD, Murray I. Craig AJ, et al. Among authors: flux gd. Q J Nucl Med Mol Imaging. 2023 Mar;67(1):4-13. doi: 10.23736/S1824-4785.22.03501-4. Epub 2023 Jan 12. Q J Nucl Med Mol Imaging. 2023. PMID: 36633588 Free article.
Leonidas D. Marinelli: Cold War Scientist.
Godfrey JM, Flux GD. Godfrey JM, et al. Among authors: flux gd. Radiat Res. 2023 Feb 1;199(2):202-210. doi: 10.1667/RADE-22-00064.1. Radiat Res. 2023. PMID: 36583945 No abstract available.
140 results